- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03832244
The Role of Sub-mental Ultrasonography in Diagnosing Obstructive Sleep Apnea and Its Correlation With Subjective Scales
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Polysomnography (PSG) is the gold-standard diagnose tool for Obstructive Sleep Apnea (OSA). However, the availability of PSG is limited, particularly in developing and / or least developed countries. Sub-mental ultrasonography is stepped forward with its practical and cheap nature and its widespread use.
The investigators aimed to perform sub-mental ultrasonography to the patients who underwent to PSG by a blind-to-the-PSG-results radiologist and analyse the correlation between ultrasound measures, Apnea-Hypopnea Index (measured by Polysomnography) and subjective OSA scales.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Bartin State Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- For study group: Patients who have been diagnosed as having obstructive sleep apnea on polysomnography
- For control group: Patients who have a negative polysomnography or normal scores from subjective scales
Description
Inclusion Criteria:
- Patient who consented for sub-mental ultrasound
Exclusion Criteria:
- Any pharyngo laryngeal anatomic abnormality
- Previous history of Obstructive sleep apnea treatment
- Previous history of surgical intervention to the pharyngo laryngeal anatomic area
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Simple snoring
Patients undergoing to Sub-mental ultrasonography with Normal sleep: Fewer than 5 events per hour measured in over-night polysomnography
|
Sub-mental ultrasonography including tongue-base thickness, retropalatal distance and the distance between lingual arteries
|
Mild OSA
Patients undergoing to Sub-mental ultrasonography with Mild sleep apnea: 5 to 14 events per hour measured in over-night polysomnography
|
Sub-mental ultrasonography including tongue-base thickness, retropalatal distance and the distance between lingual arteries
|
Moderate OSA
Patients undergoing to Sub-mental ultrasonography with Moderate sleep apnea: 15 to 29 events per hour measured in over-night polysomnography
|
Sub-mental ultrasonography including tongue-base thickness, retropalatal distance and the distance between lingual arteries
|
Severe OSA
Patients undergoing to Sub-mental ultrasonography with Severe sleep apnea: 30 or more events per hour measured in over-night polysomnography
|
Sub-mental ultrasonography including tongue-base thickness, retropalatal distance and the distance between lingual arteries
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tongue base thickness
Time Frame: Baseline
|
The closest distance between tongue base and the skin in the sagittal plane
|
Baseline
|
Retropalatal distance
Time Frame: Baseline
|
The diameter of retropalatal space in the transverse dimension
|
Baseline
|
Distance between lingual arteries
Time Frame: Baseline
|
Distance between lingual arteries in the transverse plane
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stop-Bang questionnaire
Time Frame: Baseline
|
This questionnaire evaluates the risk of sleep apnea.
Low risk of OSA: Yes to 0-2 questions Intermediate risk of OSA: Yes to 3-4 questions High risk of OSA: Yes to 5-8 questions or Yes to 2 or more of 4 STOP questions + male gender or Yes to 2 or more of 4 STOP questions + BMI > 35 kg/m2 or Yes to 2 or more of 4 STOP questions + neck circumference.
|
Baseline
|
Berlin Questionnaire
Time Frame: Baseline
|
The questionnaire consists of 3 categories related to the risk of having sleep apnea. Category 1 is positive if the total score is 2 or more points. Category 2 is positive if the total score is 2 or more points. Category 3 is positive if the answer to item 10 is 'Yes' or if the BMI of the patient is greater than 30kg/m2. (BMI is defined as weight (kg) divided by height (m) squared, i.e.., kg/m2). Patients can be classified into High Risk or Low Risk based on their responses to the individual items and their overall scores in the symptom categories. High Risk: if there are 2 or more categories where the score is positive. Low Risk: if there is only 1 or no categories where the score is positive. Total score is ranged between 0-3. |
Baseline
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline
|
The order of the PSQI items has been modified from the original order in order to fit the first 9 items (which are the only items that contribute to the total score) on a single page.
Item 10, which is the second page of the scale, does not contribute to the PSQI score.
In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty).
The component scores are summed to produce a global score (range 0 to 21).
Higher scores indicate worse sleep quality.
|
Baseline
|
Neck circumference
Time Frame: Baseline
|
Neck circumference was measured with the head erect and eyes facing forward, horizontally at the upper margin of the thyroid cartilage (to the nearest 0.1 cm)
|
Baseline
|
The thyromental distance
Time Frame: Baseline
|
The thyromental distance is defined as the distance from the chin (mentum) to the top of the notch of the thyroid cartilage with the head fully extended.
It is measured with a ruler
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ozge Yagcioglu Yassa, M.D., Coordinator of Sleep Disorders Centre of Bartin State Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BartinUyku
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
LivaNovaRecruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
-
State Key Laboratory of Respiratory DiseaseCompletedObstructive Sleep Apnea of AdultChina
-
Somnics, Inc.UnknownObstructive Sleep Apnea of AdultTaiwan
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States
Clinical Trials on Sub-mental ultrasonography
-
University of OxfordRecruitingCoronavirus Infection | Multi-Organ DisorderUnited Kingdom
-
National Institute of Neurological Disorders and...Completed
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United Kingdom; RM Partners...RecruitingSmoking | Alcoholism | Urologic Diseases | Hypertension | Diabetes | Prostate Cancer | Bladder Cancer | Renal Cancer | Urologic Cancer | Mental Health Issue | Testis CancerUnited Kingdom
-
Algos Clinical Development Thomas L. Yearwood,...TerminatedBack Pain | Back Pain With Radiation | Pain in Leg, UnspecifiedUnited States
-
Xim LimitedCompletedCardiovascular Diseases | Diabetes | Critical Care | Primary Care | Respiratory Disorder | Trauma and Emergency CareUnited Kingdom
-
Benha UniversityUnknownPostmenopausal BleedingEgypt
-
Universidad Autonoma de MadridCompletedAsymptomatic Subjects | Painfree Voluntiers | NeuroscienceSpain
-
Boston Children's HospitalUniversity of Colorado, DenverCompletedConcussion, Mild | Concussion, Brain | Concussion, Severe | Exertion; ExcessUnited States
-
University of NebraskaUniversity of Colorado, Denver; University of Pennsylvania; Stanford UniversityActive, not recruitingParkinson Disease | Sleep FragmentationUnited States
-
Hillel Yaffe Medical CenterUnknownCellulitis | Community-Acquired Pneumonia | Exacerbation of Chronic Obstructive Pulmonary Disease | Exacerbation of Chronic Heart Failure